Treatment of cells with MGH-CP1 or MGH-CP12 in vitro for 24 or 48 h before implantation, also dramatically inhibits Huh7 and MDA-MB-231 tumor initiation (Fig. 2l and Supplementary Fig. 4j–l). The gene discussed is CYP1A2; the disease is neoplasm.